Mesoblast
Price & Volume
Stats
See more52W Range | $9.88-$21.50 |
Market Cap | $1.8B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $65.3M |
Revenue Growth (YoY) | 1,526.8% |
Gross Profit (12 Mos) | -$23.2M |
Diluted EPS | -$0.74 |
News
See moreYahoo Finance • 3 days ago
Mesoblast Wins FDA IND Clearance To Fast-Track Ryoncil Trial In Duchenne Muscular Dystrophy
Yahoo Finance • 3 days ago
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy
Yahoo Finance • 4 days ago
Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter
Yahoo Finance • 23 days ago
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed
About
CEO | Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons) |
Address | 55 Collins Street, Melbourne, VIC, Australia, 3000 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |
